Annual Shareholders Equity
-$44.86 M
-$55.64 M-515.99%
December 31, 2023
Summary
- As of February 7, 2025, MCRB annual stockholders equity is -$44.86 million, with the most recent change of -$55.64 million (-515.99%) on December 31, 2023.
- During the last 3 years, MCRB annual shareholders equity has fallen by -$219.61 million (-125.67%).
- MCRB annual shareholders equity is now -121.84% below its all-time high of $205.39 million, reached on December 31, 2015.
Performance
MCRB Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$23.92 M
+$110.99 M+127.47%
September 30, 2024
Summary
- As of February 7, 2025, MCRB quarterly stockholders equity is $23.92 million, with the most recent change of +$110.99 million (+127.47%) on September 30, 2024.
- Over the past year, MCRB quarterly shareholders equity has increased by +$68.78 million (+153.32%).
- MCRB quarterly shareholders equity is now -89.24% below its all-time high of $222.20 million, reached on September 30, 2015.
Performance
MCRB Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
MCRB Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -516.0% | +153.3% |
| 3 y3 years | -125.7% | +121.8% |
| 5 y5 years | +6.6% | +121.8% |
MCRB Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -134.1% | at low | -81.8% | +127.5% |
| 5 y | 5-year | -125.7% | +7.2% | -87.3% | +127.5% |
| alltime | all time | -121.8% | +7.2% | -89.2% | +127.5% |
Seres Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $23.92 M(-127.5%) |
| Jun 2024 | - | -$87.07 M(+45.8%) |
| Mar 2024 | - | -$59.74 M(+33.2%) |
| Dec 2023 | -$44.86 M(-516.0%) | -$44.86 M(+196.6%) |
| Sep 2023 | - | -$15.12 M(-166.9%) |
| Jun 2023 | - | $22.61 M(-147.2%) |
| Mar 2023 | - | -$47.87 M(-543.9%) |
| Dec 2022 | $10.78 M(-91.8%) | $10.78 M(-84.0%) |
| Sep 2022 | - | $67.58 M(+193.1%) |
| Jun 2022 | - | $23.06 M(-71.5%) |
| Mar 2022 | - | $80.96 M(-38.4%) |
| Dec 2021 | $131.51 M(-24.7%) | $131.51 M(-25.2%) |
| Sep 2021 | - | $175.74 M(+73.9%) |
| Jun 2021 | - | $101.07 M(-29.7%) |
| Mar 2021 | - | $143.71 M(-17.8%) |
| Dec 2020 | $174.75 M(-461.6%) | $174.75 M(-7.1%) |
| Sep 2020 | - | $188.05 M(-386.8%) |
| Jun 2020 | - | -$65.58 M(+6.4%) |
| Mar 2020 | - | -$61.65 M(+27.6%) |
| Dec 2019 | -$48.32 M | -$48.32 M(+50.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | -$32.22 M(+79.3%) |
| Jun 2019 | - | -$17.97 M(-74.3%) |
| Mar 2019 | - | -$69.83 M(+45.3%) |
| Dec 2018 | -$48.05 M(-179.2%) | -$48.05 M(+57.2%) |
| Sep 2018 | - | -$30.57 M(+130.6%) |
| Jun 2018 | - | -$13.26 M(-232.1%) |
| Mar 2018 | - | $10.03 M(-83.5%) |
| Dec 2017 | $60.70 M(-54.2%) | $60.70 M(-29.0%) |
| Sep 2017 | - | $85.51 M(-2.7%) |
| Jun 2017 | - | $87.93 M(-21.1%) |
| Mar 2017 | - | $111.45 M(-16.0%) |
| Dec 2016 | $132.63 M(-35.4%) | $132.63 M(-13.9%) |
| Sep 2016 | - | $154.00 M(-8.0%) |
| Jun 2016 | - | $167.40 M(-11.8%) |
| Mar 2016 | - | $189.83 M(-7.6%) |
| Dec 2015 | $205.39 M(-868.7%) | $205.39 M(-7.6%) |
| Sep 2015 | - | $222.20 M(+134.1%) |
| Jun 2015 | - | $94.91 M(-8.9%) |
| Mar 2015 | - | $104.18 M(-489.9%) |
| Dec 2014 | -$26.72 M(+140.4%) | -$26.72 M |
| Dec 2013 | -$11.12 M | - |
FAQ
- What is Seres Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Seres Therapeutics?
- What is Seres Therapeutics annual shareholders equity year-on-year change?
- What is Seres Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Seres Therapeutics?
- What is Seres Therapeutics quarterly shareholders equity year-on-year change?
What is Seres Therapeutics annual stockholders equity?
The current annual shareholders equity of MCRB is -$44.86 M
What is the all time high annual shareholders equity for Seres Therapeutics?
Seres Therapeutics all-time high annual stockholders equity is $205.39 M
What is Seres Therapeutics annual shareholders equity year-on-year change?
Over the past year, MCRB annual stockholders equity has changed by -$55.64 M (-515.99%)
What is Seres Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of MCRB is $23.92 M
What is the all time high quarterly shareholders equity for Seres Therapeutics?
Seres Therapeutics all-time high quarterly stockholders equity is $222.20 M
What is Seres Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, MCRB quarterly stockholders equity has changed by +$68.78 M (+153.32%)